AIGEN INVESTMENT MANAGEMENT, LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$555,532
+53.4%
17,569
+69.2%
0.10%
+105.9%
Q4 2022$362,263
-46.0%
10,383
+12.5%
0.05%
-56.0%
Q1 2022$671,000
+64.1%
9,233
+81.3%
0.12%
+114.8%
Q1 2021$409,000
-18.4%
5,093
-44.7%
0.05%
-16.9%
Q4 2020$501,000
-73.4%
9,212
-89.7%
0.06%
-73.1%
Q2 2020$1,883,000
+301.5%
89,571
+133.6%
0.24%
+290.3%
Q1 2020$469,00038,3500.06%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders